0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Advocacy at a Glance Guest User 4/3/20 Advocacy at a Glance Guest User 4/3/20

Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA

Read More
Advocacy at a Glance Guest User 3/27/20 Advocacy at a Glance Guest User 3/27/20

FDA Gains $80 Million in Third Pandemic Relief Bill

Read More
Advocacy at a Glance Guest User 3/20/20 Advocacy at a Glance Guest User 3/20/20

Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides

Read More
Advocacy at a Glance Guest User 3/13/20 Advocacy at a Glance Guest User 3/13/20

The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely

Read More
Advocacy at a Glance Guest User 3/6/20 Advocacy at a Glance Guest User 3/6/20

Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate

Read More
Advocacy at a Glance Guest User 2/28/20 Advocacy at a Glance Guest User 2/28/20

Coronavirus Supplemental Likely to Be Considered Quickly

Read More
Advocacy at a Glance Guest User 2/21/20 Advocacy at a Glance Guest User 2/21/20

Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation

Read More
Advocacy at a Glance Guest User 2/14/20 Advocacy at a Glance Guest User 2/14/20

President Proposes Small FY 21 Increase for FDA

Read More
Advocacy at a Glance Guest User 2/7/20 Advocacy at a Glance Guest User 2/7/20

Upcoming Alliance Events

Read More
Advocacy at a Glance Guest User 2/1/20 Advocacy at a Glance Guest User 2/1/20

Upcoming Hill Opportunity for Alliance Members

Read More
Advocacy at a Glance Guest User 1/25/20 Advocacy at a Glance Guest User 1/25/20

Notes from the Alliance Meeting with CBER Director, Dr. Peter Marks

Read More
Advocacy at a Glance Guest User 1/17/20 Advocacy at a Glance Guest User 1/17/20

The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington

Read More
Advocacy at a Glance Guest User 1/10/20 Advocacy at a Glance Guest User 1/10/20

Before Focusing on FY 21 Funding: A Recap of FY 20

Read More
Advocacy at a Glance Guest User 12/20/19 Advocacy at a Glance Guest User 12/20/19

FY 20 Appropriations: Headed to the President for His Signature

Read More
Advocacy at a Glance Guest User 12/16/19 Advocacy at a Glance Guest User 12/16/19

Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday

Read More
Advocacy at a Glance Guest User 12/8/19 Advocacy at a Glance Guest User 12/8/19

The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems

Read More
Advocacy at a Glance Guest User 11/22/19 Advocacy at a Glance Guest User 11/22/19

Continuing Resolution Extends Funding through December 20

Read More
Advocacy at a Glance Guest User 11/15/19 Advocacy at a Glance Guest User 11/15/19

Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close

Read More
Advocacy at a Glance Guest User 11/11/19 Advocacy at a Glance Guest User 11/11/19

A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December

Read More
Advocacy at a Glance Guest User 11/1/19 Advocacy at a Glance Guest User 11/1/19

Senate Passes First Minibus, Which Includes Ag/FDA Funding

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.